Investing Profile

Steve Weinstein

Angel
Venture Investor, CEO and Life Science Executive
Cambridge, Massachusetts
Photo of Steve Weinstein, Angel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Angel
$5K - $50K
$25K
9
CompanyStageDateRound SizeTotal Raised
Syndicate
SeedJun 2021$800K
$28M
Co-investors: Ali Yahya (Andreessen Horowitz), Curtis Spencer (Electric Capital), Ken Deeter (Electric Capital), Maria Shen (Electric Capital), Courtney Chow (Battery Ventures), David Eckstein (Sequoia Capital), Matthew Ball (Makers Fund), Lenny Rachitsky (AirAngels), Baek Kim (Hashed), Illia Polosukhin (SID Venture Partners), Raj Gokal (Solana Ventures), Min Teo (Ethereal Ventures), Todd Goldberg (Todd and Rahul's Angel Fund), Joyce Yang (Seed Club Ventures), Jeff Morris, Jr. (Chapter One Ventures), Rahul Vohra (Todd and Rahul's Angel Fund), Tom Bedecarre (WPP Ventures), Alexander Pack (Hack VC), Niraj Pant (Hack VC), Ash Egan (Archetype), Tom Shaughnessy Jr (Seed Club Ventures), Jake Brukhman (CoinFund), Tarun Chitra (Robot Ventures), Monica Desai Weiss (Kleiner Perkins), Dan Elitzer (Nascent), Robert Leshner (Robot Ventures), Jalak Jobanputra (Future Perfect Ventures), Packy McCormick (Not Boring Capital), Ryan Hoover (Weekend Fund), Erikan Obotetukudo (Audacity), Gabby Dizon (Infinity Ventures Crypto), Julia Lipton (Awesome People Ventures), George Lambeth (Divergence Ventures), Calvin Liu (Divergence Ventures), Sriram Krishnan (Kearny Jackson), Stani Kulechov, Tegan Kline, Andrew Steinwold, Trevor McFedries, Anastasia Andrianova, Alice Lloyd George, Imran Khan, Regan Bozman, Tyler Scott Ward, Rene Reinsberg, Jess Sloss, Sina Habibi, Luis Cuende, Bo Shao, Eric Wu, Nathaniel Whittemore, Alex Pack, Do Kwon, David Nage, Adam Jackson, Biz Stone
ROX Medical
Series ESep 2016$40M
$89M
Co-investors: Kim P. Kamdar (Domain Associates)
Realeve
Series DJun 2015$43M
Series DMay 2015$38M
Series COct 2011$32M
$110M
Co-investors: Martien van Osch (Forbion), Olivier Litzka (Andera Partners)
Visiogen
Series DMay 2009$40M
$64M
Co-investors: Andrew Firlik (Jazz Venture Partners)
iScience Interventional
Series FMay 2009$21M
Series CApr 2003$15M
$36M
Ablation Frontiers
Series CJul 2007$22M
$22M
Managing Director Novartis Venture Fund2006 - 2018